Rang	Name	Position
1	Mr. Rami Elghandour	Chairman of the Board, CEO & President
2	Ms. Michelle Lim Gilson	Chief Financial Officer
3	Ms. Aileen Fernandes	Chief Operating Officer
4	Mr. Narinderjeet Singh M.S.	Chief Technical Officer
5	Dr. Heba Nowyhed Ph.D.	Chief Scientific Officer
6	Ms. Myesha Lacy	Chief Investor & Communications Officer
7	Ms. Maryam Abdul-Kareem J.D., M.S.	General Counsel & Chief Legal Officer
8	Ms. Kate Aiken	Chief People Officer
9	Mr. Neeraj P. Teotia	Chief Commercial Officer
10	Ms. Helen Kim	VP & Head of Regulatory Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Paradigm Biocapital Advisors LP	9,87%	0,66 Mrd. USD
2	Vanguard Group Inc	6,98%	0,47 Mrd. USD
3	BlackRock Inc	6,74%	0,45 Mrd. USD
4	NEA Management Company, LLC	5,21%	0,35 Mrd. USD
5	Pentwater Capital Management LP	4,91%	0,33 Mrd. USD
6	Vanguard Capital Management, LLC	4,15%	0,28 Mrd. USD
7	Vanguard Portfolio Management, LLC	4,14%	0,28 Mrd. USD
8	SR ONE CAPITAL MANAGEMENT, LP	4,01%	0,27 Mrd. USD
9	Fidelity International Ltd	4,00%	0,27 Mrd. USD
10	HBK INVESTMENTS L P	3,89%	0,26 Mrd. USD
11	T. Rowe Price Investment Management,Inc.	3,86%	0,26 Mrd. USD
12	State Street Corp	2,86%	0,19 Mrd. USD
13	Glazer Capital, LLC	2,58%	0,17 Mrd. USD
14	The Goldman Sachs Group Inc	2,24%	0,15 Mrd. USD
15	Geode Capital Management, LLC	1,76%	0,12 Mrd. USD
16	Morgan Stanley - Brokerage Accounts	1,58%	0,11 Mrd. USD
17	JPMorgan Chase & Co	1,01%	0,07 Mrd. USD
18	Davidson Kempner Capital Management LP	0,96%	0,06 Mrd. USD
19	AllianceBernstein L.P.	0,93%	0,06 Mrd. USD
20	Test Hedge Fund Mgmt	0,93%	0,06 Mrd. USD